Evotec SE (EVO) Divestments (2025 - 2026)
Evotec SE (EVO) posted Divestments of -$4512.1 for Q1 2026, down 100.0% sequentially from $258.8 million in Q4 2025.
Evotec SE (EVO) Divestments (2025 - 2026) Analysis & Trends
Evotec SE has reported Divestments for 2 years, with the latest figure at -$4512.1 in Q1 2026.
- Quarterly Divestments changed N/A year-over-year to -$4512.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $258.8 million (changed N/A YoY) and the FY2025 annual result came in at $258.8 million, up 2205.47% from the prior year.
- Divestments declined to -$4512.1 in Q1 2026 per EVO's latest filing, from $258.8 million in the prior quarter.
- Over five years, Divestments peaked at $258.8 million in Q4 2025 and troughed at -$4512.1 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.87 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 32.51 Bn | 30.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.66 Bn | 22.86 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.83 Bn | 17.94 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Evotec SE | 681.90 Mn | 681.42 Mn | - | -4,512.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,512.05 |
| Dec 31, 2025 | 258.81 Mn |